DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zota Health Care LImited — Certificate under SEBI (Depositories and Participants) Regulations, 2018

NSE 51 min ago·15 Oct 2026, 5:33 am

Zota Health Care

Zota Health Care Limited has informed stock exchanges that it has obtained a certificate under SEBI’s (Depositories and Participants) Regulations, 2018. This compliance document confirms that the company has met the necessary requirements to operate as a Depository Participant. It serves as an official declaration of adherence to the regulatory framework governing share settlements and dematerialization processes.

For investors, this development is a positive signal regarding the company's corporate governance and operational readiness. It indicates that Zota Health Care is fully aligned with market standards, which can enhance transparency and trust. While this is a routine regulatory milestone, it ensures the company is fully equipped to handle its shareholding and trading activities efficiently.

Investors should monitor the company's future announcements to see if this compliance leads to any new business initiatives or expansions. As this is a procedural update, it does not immediately impact the stock's price, but it reinforces the company's commitment to regulatory compliance.